DTaP poliovirus vaccine (Kaketsuken)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTaP poliovirus vaccine (Kaketsuken)

Drug Alias NameDTaP-IPV combination vaccine (Kaketsuken)DTaP脊髓灰质炎病毒疫苗 - KaketsukenKD-332

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKM Biologics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKM Biologics Co Ltd

Active IndicationsN/A

Inactive IndicationsPoliomyelitisTetanusDiphtheria +[4]

Other Information

ATC CodeN/A